“Avian Influenza A/H7N9 Vaccine Mixed with MF59 Adjuvant at the Point-of-Use. A Randomized Clinical Trial of a Pandemic Threat Response.”, in ID Week 2014, Philadelphia, PA, 2014.
, “VRC 702: A Multicenter Phase 1 Study of Seasonal Influenza DNA Vaccine Prime Followed by the Trivalent Inactivated Vaccine (TIV) Compared to TIV-TIV in Children and Adolescents Ages 6-17 Years”, in 2014 Annual Conference on Vaccine Research, Bethesda, MD, 2014.
, “Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women”, J Infect Dis, vol. 209, pp. 828-836, 2014.
, “Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine”, J Infec Dis, vol. 181, pp. 11133-7, 2000.
, “Diminution of the Anti-PRP response to a combined DtaP/Hib vaccine by concurrent inactivated poliovirus vaccination”, Ped J Infec Dis, vol. 19, pp. 417-23, 2000.
, “DNA Priming for Seasonal Influenza Vaccine: a Phase 1b Double-Blind Randomized Clinical Trial”, PLoS One, vol. 10, p. e0125914, 2015.
, “Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults”, J Infec Dis, vol. 197, pp. 667-675, 2008.
, “The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children”, N Engl J Med, vol. 338, pp. 1405-12, 1998.
, “Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine”, J Pediatric, vol. 136, pp. 168-175, 2000.
, “Efficacy Results of A Trial of A Herpes Simplex Vaccine”, N Engl J Med, vol. 366, pp. 34-43, 2012.
, “Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women”, Clin Infect Dis, vol. 56, pp. 344-351, 2013.
, “HSV-1 and HSV-2 Seroprevalence in the United States Among Asymptomatic Women Unaware of any Herpes Simplex Virus Infection (Herpevac Trial for Women)”, Southern Medical Journal, vol. 107, pp. 79-84, 2014.
, “Immunogenicity and Safety of Four Different Dosing Regimens of Anthrax Vaccine Adsorbed for Post-Exposure Prophylaxis for Anthrax in Adults”, Vaccine, vol. 32, pp. 6284-6293, 2014.
, “Norovirus Vaccine Against Experimental Human Norwalk Virus Illness”, N Engl J Med, vol. 365, pp. 2178-2187, 2011.
, “A Phase I Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimeric Vaccines”, J Infec Dis, vol. 193, pp. 1350-1360, 2006.
, “Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations”, Vaccine, vol. 33, pp. 163-173, 2015.
, “Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations”, J Infect Dis, vol. 206, pp. 828-837, 2012.
, “Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine”, J Amer Med Assn, vol. 292, pp. 1205-1212, 2004.
,